Emily Dotson
Overview
Explore the profile of Emily Dotson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Braunstein Z, Waller A, Dotson E, McLaughlin E, Hanel W, Reneau J, et al.
Leuk Lymphoma
. 2023 Dec;
65(3):301-311.
PMID: 38093530
Aggressive T-cell lymphomas (TCL) account for 10-15% of non-Hodgkin lymphomas (NHL) with weaker responses and shorter durations to chemotherapy than other types of NHL. Current therapies for patients with relapsed/refractory...
2.
Fleming M, Huang Y, Dotson E, Bond D, Reneau J, Epperla N, et al.
Ther Adv Hematol
. 2022 Jul;
13:20406207221112900.
PMID: 35898434
Background: The optimal treatment of patients with systemic diffuse large B-cell (DLBCL) or high-grade B-cell (HGBL) lymphomas with synchronous central nervous system (CNS) involvement at diagnosis is not well defined....
3.
Fleming M, Huang Y, Dotson E, Bond D, Reneau J, Epperla N, et al.
Blood Adv
. 2021 Nov;
6(2):460-472.
PMID: 34788387
The optimal timing for administering high-dose methotrexate (HDMTX) when combined with (R)CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone, with/without rituximab) is unclear. Recent data showed that the administration of prophylactic HDMTX before...
4.
Bond D, Dotson E, Awan F, Baiocchi R, Blum K, Maddocks K
Clin Lymphoma Myeloma Leuk
. 2018 Dec;
19(3):e123-e128.
PMID: 30594446
No abstract available.
5.
Rogers K, Huang Y, Dotson E, Lundberg J, Andritsos L, Awan F, et al.
Br J Haematol
. 2018 Jul;
185(2):363-366.
PMID: 30028000
No abstract available.
6.
Fajardo S, Zook F, Dotson E
Am J Health Syst Pharm
. 2016 Apr;
73(11):797-809.
PMID: 27126835
Purpose: The oral oncology medications used in the treatment of chronic lymphocytic leukemia, chronic myeloid leukemia, multiple myeloma, and non-Hodgkin's lymphoma are reviewed, and the specialty pharmacy services at three...
7.
Dotson E, Crawford B, Phillips G, Jones J
Support Care Cancer
. 2015 Aug;
24(3):1125-9.
PMID: 26268782
Purpose: Rituximab is a chimeric monoclonal antibody approved to treat B cell non-Hodgkin's lymphoma (NHL). Infusion reactions among NHL patients are common during the first exposure but decrease with subsequent...
8.
Wiczer T, Dotson E, Tuten A, Phillips G, Maddocks K
J Oncol Pharm Pract
. 2015 Jul;
22(3):430-6.
PMID: 26152702
Introduction: High-dose methotrexate (doses ≥1 g/m(2)) is a key component of several chemotherapy regimens used to treat patients with leukemia or lymphoma. Despite appropriate precautions with hydration, urine alkalinization, and...
9.
Arnold T, Dotson E, Sarosi G, Hage C
Proc Am Thorac Soc
. 2010 May;
7(3):222-8.
PMID: 20463252
Invasive mycoses continue to be a major problem in the growing population of immunosuppressed patients. More antifungal agents are now available than ever. The options are many, with more efficacies...